Addressing high false-positive rates for mammograms

June 13, 2011 in Cancer

We've heard it repeatedly: early detection is key to surviving breast cancer. But even with recent advances in mammography, finding indications of breast cancer before it can metastasize remains a problem. Scientists at Pacific Northwest National Laboratory and Duke University Medical Center have increased the ability to determine if a positive result on a breast cancer screen is true or false.

They found that different subtypes produce distinct profiles of in blood and that these biomarkers have the potential to differentiate between true and false positive screens. These subtype-specific biomarker panels may also be useful as an additional way to detect breast cancer.

High false-positive rates for mammograms have become a controversial issue in the last 2 years, and have been reported by the popular press. Existing for breast cancer are commonly incorrect in that the majority of times a suspicious lump is found, it is not cancer. Therefore, alternative tests are needed to either assist in early detection of this common form of cancer, which kills more than 40,000 women each year in the United States, or improve the existing methods' accuracy.

One potential alternative is the use of circulating biomarkers for , when the disease is more readily cured, and typically the cure does requires less harsh interventions. However, established breast are not useful for detecting the disease. information suggests that breast cancer is composed of five major subtypes. The PNNL/Duke team determined whether breast cancer subtypes influence circulating protein biomarkers. Their results suggest that patterns of circulating biomarkers are not only influenced by breast-cancer subtype, but that it may be essential to consider breast cancer subtypes when using biomarkers in blood.

The researchers used a sandwich-ELISA microarray platform to evaluate 23 candidate biomarkers in plasma samples from people having either benign breast disease or invasive breast cancer. The platform can analyze multiple biomarkers quickly and efficiently. An important aspect of this study is that the plasma samples were collected when the patients had biopsies, which were done based on a suspicious screening test, such as a mammogram. Thus, both the patients and persons collecting the blood were ignorant of the presence or absence of cancer. Based on the results of the biopsy analysis, breast cancer subtypes were defined based on the HER2 and estrogen receptor statuses.

The researchers found that ten proteins were altered in at least one breast cancer subtype. But only one protein, the cytokine RANTES, was significantly increased in all four subtypes. Even so, the best discrimination was obtained with analyses that combined data from multiple biomarkers, and were dependent upon cancer subtype.

Although the results for RANTES are consistent with previous publications, the multi-assay results need to be validated in independent sample sets.

More information: Gonzalez RM, et al. 2011. "Plasma Biomarker Profiles Differ Depending on Breast Cancer Subtype but RANTES is Consistently Increased." Cancer Epidemiology, Biomarkers & Prevention Published Online First May 17, 2011. doi: 10.1158/1055-9965.EPI-10-1248

Provided by Pacific Northwest National Laboratory search and more info website

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

American cancer society celebrates 100 years of progress

(HealthDay)—The American Cancer Society, which is celebrating on Wednesday a century of fighting a disease once viewed as a death sentence, is making a pledge to put itself out of business.

Cancer created 9 hours ago | popularity not rated yet | comments 0

CT detects twice as many lung cancers as X-ray at initial screening exam

National Lung Screening Trial (NLST) investigators also conclude that the 20 percent reduction in lung cancer mortality with low-dose computed tomography (LDCT) versus chest X-ray (CXR) screening previously reported in the ...

Cancer created 9 hours ago | popularity not rated yet | comments 0

Research offers promising new approach to treatment of lung cancer

Researchers have developed a new drug delivery system that allows inhalation of chemotherapeutic drugs to help treat lung cancer, and in laboratory and animal tests it appears to reduce the systemic damage ...

Cancer created 13 hours ago | popularity not rated yet | comments 0 | with audio podcast

Study details genes that control whether tumors adapt or die when faced with p53 activating drugs

When turned on, the gene p53 turns off cancer. However, when existing drugs boost p53, only a few tumors die – the rest resist the challenge. A study published in the journal Cell Reports shows how: tumors that live even i ...

Cancer created 13 hours ago | popularity not rated yet | comments 0 | with audio podcast

Small increase in cancer risk following CT scans in childhood and adolescence

Study leader, Professor John Mathews from the University of Melbourne said this small increase in cancer risk must be weighed against the undoubted benefits from CT scans in diagnosing and monitoring disease.

Cancer created 17 hours ago | popularity not rated yet | comments 0


Rate of bicycle-related fatalities significantly lower in states with helmet laws

Existing research shows that bicyclists who wear helmets have an 88 percent lower risk of brain injury, but researchers at Boston Children's Hospital found that simply having bicycle helmet laws in place showed a 20 percent ...

Slowing the aging process—only with antibiotics

Swiss scientists reveal the mechanism responsible for aging hidden deep within mitochondria—and dramatically slow it down in worms by administering antibiotics to the young.

Researchers complete largest genetic sequencing study of human disease

Researchers from Queen Mary, University of London have led the largest sequencing study of human disease to date, investigating the genetic basis of six autoimmune diseases.

Brain can be trained in compassion, study shows

Until now, little was scientifically known about the human potential to cultivate compassion—the emotional state of caring for people who are suffering in a way that motivates altruistic behavior.

Having both migraines, depression may mean smaller brain

(HealthDay)—Migraines and depression can each cause a great deal of suffering, but new research indicates the combination of the two may be linked to something else entirely—a smaller brain.

Novel approach for influenza vaccination shows promise in early animal testing

A new approach for immunizing against influenza elicited a more potent immune response and broader protection than the currently licensed seasonal influenza vaccines when tested in mice and ferrets. The vaccine ...